ANN BOND: Open Payments
NPI 1528322120 · UNIVERSITY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 4 companies in 2025. Trend: 2023 $561 · 2024 $463 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Brainsway USA INC | 1 | $12 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, SPRAVATO, Deep TMS System.
Industry payments across MS — which companies pay providers there.
